Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-23

Clinical Trial Update: Effect of Elderberry Juice on Cognition and Inflammation in Patients With Mild Cognitive Impairment [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial assessing elderberry juice effects on cognition and inflammation in mild cognitive impairment patients has completed phases 1 and 2 with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • elderberry juice

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Mild Cognitive Impairment | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-23